DBV Technologies (DBVT) Competitors $0.59 +0.03 (+5.36%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends DBVT vs. KOD, INZY, EDIT, LFCR, CMPX, TSVT, CRBU, OPT, ATAI, and ATYRShould you be buying DBV Technologies stock or one of its competitors? The main competitors of DBV Technologies include Kodiak Sciences (KOD), Inozyme Pharma (INZY), Editas Medicine (EDIT), Lifecore Biomedical (LFCR), Compass Therapeutics (CMPX), 2seventy bio (TSVT), Caribou Biosciences (CRBU), Opthea (OPT), Atai Life Sciences (ATAI), and Atyr PHARMA (ATYR). These companies are all part of the "pharmaceutical products" industry. DBV Technologies vs. Kodiak Sciences Inozyme Pharma Editas Medicine Lifecore Biomedical Compass Therapeutics 2seventy bio Caribou Biosciences Opthea Atai Life Sciences Atyr PHARMA Kodiak Sciences (NASDAQ:KOD) and DBV Technologies (NASDAQ:DBVT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, community ranking, profitability, earnings and institutional ownership. Which has more risk & volatility, KOD or DBVT? Kodiak Sciences has a beta of 2.26, indicating that its share price is 126% more volatile than the S&P 500. Comparatively, DBV Technologies has a beta of 0.66, indicating that its share price is 34% less volatile than the S&P 500. Do institutionals & insiders have more ownership in KOD or DBVT? 89.1% of Kodiak Sciences shares are owned by institutional investors. Comparatively, 71.7% of DBV Technologies shares are owned by institutional investors. 45.3% of Kodiak Sciences shares are owned by insiders. Comparatively, 1.9% of DBV Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has preferable earnings & valuation, KOD or DBVT? DBV Technologies has higher revenue and earnings than Kodiak Sciences. Kodiak Sciences is trading at a lower price-to-earnings ratio than DBV Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKodiak SciencesN/AN/A-$260.49M-$3.76-1.47DBV Technologies$15.73M3.62-$72.73M-$0.90-0.66 Does the media favor KOD or DBVT? In the previous week, Kodiak Sciences had 3 more articles in the media than DBV Technologies. MarketBeat recorded 10 mentions for Kodiak Sciences and 7 mentions for DBV Technologies. Kodiak Sciences' average media sentiment score of 0.31 beat DBV Technologies' score of 0.04 indicating that Kodiak Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kodiak Sciences 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DBV Technologies 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate KOD or DBVT? Kodiak Sciences currently has a consensus price target of $3.50, indicating a potential downside of 36.71%. DBV Technologies has a consensus price target of $6.00, indicating a potential upside of 917.29%. Given DBV Technologies' stronger consensus rating and higher possible upside, analysts clearly believe DBV Technologies is more favorable than Kodiak Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kodiak Sciences 2 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50DBV Technologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is KOD or DBVT more profitable? Kodiak Sciences has a net margin of 0.00% compared to DBV Technologies' net margin of -815.73%. Kodiak Sciences' return on equity of -77.23% beat DBV Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Kodiak SciencesN/A -77.23% -42.44% DBV Technologies -815.73%-106.07%-76.17% Does the MarketBeat Community favor KOD or DBVT? DBV Technologies received 385 more outperform votes than Kodiak Sciences when rated by MarketBeat users. Likewise, 55.51% of users gave DBV Technologies an outperform vote while only 26.47% of users gave Kodiak Sciences an outperform vote. CompanyUnderperformOutperformKodiak SciencesOutperform Votes1826.47% Underperform Votes5073.53% DBV TechnologiesOutperform Votes40355.51% Underperform Votes32344.49% SummaryDBV Technologies beats Kodiak Sciences on 9 of the 17 factors compared between the two stocks. Ad DTILet’s be bluntLet me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now Get DBV Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DBVT vs. The Competition Export to ExcelMetricDBV TechnologiesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$56.92M$2.91B$5.07B$8.66BDividend YieldN/A1.79%5.10%4.06%P/E Ratio-0.6643.08101.9217.46Price / Sales3.62217.681,196.9569.07Price / CashN/A178.0141.0436.36Price / Book1.054.096.345.87Net Income-$72.73M-$42.42M$119.64M$225.66M7 Day Performance-12.62%-10.63%-5.13%-1.34%1 Month Performance-19.21%-5.81%-2.72%1.15%1 Year Performance-66.10%24.19%31.10%24.02% DBV Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DBVTDBV Technologies2.8874 of 5 stars$0.59+5.4%$6.00+917.3%-65.5%$56.92M$15.73M-0.66106Analyst ForecastStock SplitShort Interest ↑Gap UpKODKodiak Sciences3.2747 of 5 stars$4.92+2.3%N/A+188.0%$258.89MN/A-1.3190Analyst ForecastNews CoverageINZYInozyme Pharma1.8318 of 5 stars$4.02-2.0%N/A-3.0%$258.25MN/A-2.5850EDITEditas Medicine4.6327 of 5 stars$3.12-1.6%N/A-69.7%$257.55M$61.76M-1.22230Short Interest ↓LFCRLifecore Biomedical2.7081 of 5 stars$6.74+5.5%N/A-13.9%$248.23M$128.26M84.25690CMPXCompass Therapeutics3.4565 of 5 stars$1.80-2.2%N/A-8.0%$247.66MN/A-4.8620Earnings ReportAnalyst DowngradeShort Interest ↓Analyst RevisionNews CoverageGap UpTSVT2seventy bio2.4915 of 5 stars$4.73-5.6%N/A+66.4%$243.60M$100.39M-1.54440News CoverageCRBUCaribou Biosciences2.9838 of 5 stars$2.68-3.6%N/A-57.9%$242.17M$34.48M-1.62100Analyst ForecastShort Interest ↓News CoverageOPTOpthea2.3603 of 5 stars$4.11+1.7%N/A+72.3%$240.00M$124,666.000.008News CoverageATAIAtai Life Sciences2.4707 of 5 stars$1.41+4.4%N/A+45.0%$236.60M$310,000.00-3.5283News CoverageGap UpHigh Trading VolumeATYRAtyr PHARMA2.996 of 5 stars$3.12+0.6%N/AN/A$236.50M$350,000.00-3.3256Short Interest ↑News Coverage Related Companies and Tools Related Companies Kodiak Sciences Alternatives Inozyme Pharma Alternatives Editas Medicine Alternatives Lifecore Biomedical Alternatives Compass Therapeutics Alternatives 2seventy bio Alternatives Caribou Biosciences Alternatives Opthea Alternatives Atai Life Sciences Alternatives Atyr PHARMA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DBVT) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DBV Technologies S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share DBV Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.